Literature DB >> 1923951

Plurihormonal adenomas. Analysis of 62 cases.

T Kameya1, S Furuhata.   

Abstract

This paper deals with the cytological features of pituitary plurihormonal adenomas based on 62 cases examined by histology, immunohistochemistry, ultrastructural study and post-embedding immunogold electron microscopy, including double labeling. In GH-cell containing adenomas, there were 9 adenomas consisting of exclusively GH and PRL cells. The other 39 adenomas contained other hormones as well as GH and PRL. Other nine combinations of pituitary hormones or alpha-subunit were observed. Special emphasis was laid on the fact that a greater part of GH-producing adenomas (74% by immunostain) were PRL-producing, although the ratio of GH-cells to PRL-cells widely varied from case to case. Concerning the double labeling study on mixed GH-PRL secreting adenomas, we recognized the existence of secretory granules containing GH only, those containing PRL only, those containing both GH and PRL and those containing neither.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923951     DOI: 10.1016/S0344-0338(11)80147-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.

Authors:  J Flitsch; D K Lüdecke; N Stahnke; J Wiebel; W Saeger
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

2.  Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.

Authors:  M C Vantyghem; C Cortet; C Bauters; M H Gevaert; D Dewailly; J Lefebvre; M Mazzucca
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

3.  Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays.

Authors:  Zhiquan Jiang; Songbai Gui; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2012-05-16       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.